Karuna Therapeutics Inc (NASDAQ:KRTX)
| 82.31 Delayed Data As of 4:00pm ET |  -7.20 / -8.04%Today’s Change | 11.24 Today|||52-Week Range 152.00 | +9.25% Year-to-Date |
Latest KRTX News | Press Releases
| 3 Recent IPOs to Add to Your Watch List Feb 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 89.51 |
| Today’s open | 89.61 |
| Day’s range | 82.11 - 90.60 |
| Volume | 301,642 |
| Average volume (3 months) | 681,345 |
| Market cap | $2.5B |
Data as of 4:00pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | -190.37% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FTSVForty Seven Inc | +1.19 | +2.45% |
| ---- | ||
| RARXRa Pharmaceuticals I... | +0.06 | +0.13% |
| ARNAArena Pharmaceutical... | -1.48 | -3.01% |
Data as of 4:00pm ET, 02/25/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
